Found 88 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
PHASE1The primary purpose of this study is to determine the safety and efficacy o...
Location
The Affiliated People's Hospital of Ningbo University
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
PHASE2This phase II trial tests how well giving dasatinib and quercetin with cycl...
Location
Mayo Clinic in Rochester
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
PHASE1This study is a single-center, open Phase I study, to observe the effective...
Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT
PHASE2This is a prospective study comparing autologous hematopoietic stem cell tr...
Location
The Affiliated Hospital oh Xuzhou Medical University
Clinical Study of T Cell Infusion Targeting BCMA Chimeric Antigen Receptor
EARLY_PHASE1Chimeric antigen receptor T cells (car-t) is one of the most effective ther...
Location
No.3, Qingchun East Road
Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study
EARLY_PHASE1A Single-Center, Open-Label, Single-Arm Exploratory Clinical Study on the U...
Location
Foresea Life Insurance Guangzhou General Hospital
IASO104 for the Treatment of Patients With Relapsed/Refractory Multiple Myeloma
EARLY_PHASE1This study is a single-center, open-label, dose-exploration trial designed ...
Location
Multiple Locations
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
PHASE2The goal of this clinical trial is to test the safety and potential benefit...
Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Targeting CD19 and BCMA CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1Evaluation the safety,tolerability, preliminary efficacy,and PK/PD of KQ-20...
Location
Hematology Department of ShanXi Cancer Hospital
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
PHASE1This is a single-center, non-randomized study to evaluate the safety and ef...
Location
Peking Union Medical College Hospital